Evolv Technologies Settles Stockholder Derivative Lawsuits; No Company Payment

What Happened
Evolv Technologies Holdings, Inc. announced that on August 6, 2026 the U.S. District Court for the District of Massachusetts preliminarily approved a settlement resolving multiple stockholder derivative claims against the company. The Stipulation and Agreement of Settlement is dated August 5, 2026 and the company filed the related Form 8‑K in early August. The Settlement resolves the consolidated Massachusetts derivative action (In re Evolv Technologies Holdings, Inc. Stockholder Derivative Litigation), two Delaware Court of Chancery derivative actions (Bersch v. George and Patrick v. Charlton), and a pre‑suit demand by stockholder Nicholas R. Ingrao.

Key Details

• Court preliminary approval granted August 6, 2026; Stipulation dated August 5, 2026.
• The Settlement requires Evolv to implement certain corporate governance enhancements (specifics in the Stipulation/Notice).
• No payment is required from Evolv; plaintiffs' attorneys’ fees and expenses of $1,275,000 will be paid by the company’s insurers.
• The Company filed the Notice and Stipulation as exhibits to the Form 8‑K and posted them on its investor relations website.

Why It Matters
The settlement resolves ongoing derivative litigation and reduces legal uncertainty for the company without requiring a cash payout by Evolv, though insurers will cover plaintiffs’ fees. Corporate governance enhancements required by the Settlement could affect board oversight and procedures going forward. Investors should note the legal risk is materially diminished for these matters, and details are available in the filed Stipulation and Notice on Evolv’s investor relations page.